Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase 4 3Phase NA 2Phase 2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Osteoporosis, Postmenopausal 1Osteoporosis 1

Interventions

Exercise 216Blood Specimen Collection 122Surveys and Questionnaires 117Standard of Care 114Magnetic Resonance Spectroscopy 113Early Intervention, Educational 108Educational Status 102Methods 101Radiotherapy 94Radiosurgery 76Counseling 72Control Groups 64Biopsy 61Acupuncture Therapy 60Therapeutics 57Psychiatric Rehabilitation 55Resistance Training 52Saline Solution 49Cyclophosphamide 48Palliative Care 46Practice Guidelines as Topic 41Cognitive Behavioral Therapy 41Yoga 40Metformin 40Interviews as Topic 40Drug Therapy 37Surgical Procedures, Operative 36Radiofrequency Ablation 35Dexmedetomidine 35Colonoscopy 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Completed × Risedronic Acid × Clear all
NCT00567606 2023-11-30

Prevention of Osteoporosis in Breast Cancer Survivors

University of Nebraska

Phase NA Completed
249 enrolled

Osteoporosis, Postmenopausal

NCT00118508 2015-08-13

The Prevention of Osteoporosis in Premenopausal and Newly Postmenopausal (Up to 8 Years) Women With Breast Cancer Following Chemotherapy (REBBeCA Study)

University of Pittsburgh

Phase NA Completed
87 enrolled

Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡